Chair: Aarti Sawant, PhD (she/her/hers) – AstraZeneca
Chair: Mike Liao, PhD – Genentech
Speaker: Neali Lucas, PhD (she/her/hers) – US Food and Drug Administration
Speaker: Anuradha Ramamoorthy, PhD – Potomac, MD
Speaker: Brian Corrigan, PhD – Pfizer
Speaker: Sebastian Haertter, PhD (he/him/his) – Translational Med & Clin Pharmacology, Boehringer-Ingelheim
Speaker: Yasuto Otsubo – PMDA
Speaker: Islam R. Younis, PhD – Merck, Inc
Speaker: Sreeneeranj Kasichayanula, PhD (he/him/his) – Gilead Sciences
Speaker: Michael A. Pacanowski, PharmD – US Food and Drug Administration
Quantitative Pharmacology (QP)
Chair: Aarti Sawant, PhD (she/her/hers) – AstraZeneca
### she/her/hers @@@ Mike Liao, PhD – Genentech ### 1770938###Chair###Senior Principal Scientist###Genentech###Chair: Mike Liao, PhD – Genentech
### @@@ Neali Lucas, PhD (she/her/hers) – US Food and Drug Administration ### 2276500###Speaker###Senior Science Advisor###US Food and Drug Administration###Speaker: Neali Lucas, PhD (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Anuradha Ramamoorthy, PhD – Potomac, MD ### 1156653###Speaker######Potomac, MD###Speaker: Anuradha Ramamoorthy, PhD – Potomac, MD
### @@@ Brian Corrigan, PhD – Pfizer ### 1154047###Speaker###Global Head Clinical Pharmacology###Pfizer###Speaker: Brian Corrigan, PhD – Pfizer
### @@@ Sebastian Haertter, PhD (he/him/his) – Translational Med & Clin Pharmacology, Boehringer-Ingelheim ### 1616653###Speaker###Clinical Pharmacology Expert###Translational Med & Clin Pharmacology, Boehringer-Ingelheim###Speaker: Sebastian Haertter, PhD (he/him/his) – Translational Med & Clin Pharmacology, Boehringer-Ingelheim
### he/him/his @@@ Yasuto Otsubo – PMDA ### 2172935###Speaker###Review Director###PMDA###Speaker: Yasuto Otsubo – PMDA
### @@@ Islam R. Younis, PhD – Merck, Inc ### 1070932###Speaker###Senior Director###Merck, Inc###Speaker: Islam R. Younis, PhD – Merck, Inc
### @@@ Sreeneeranj Kasichayanula, PhD (he/him/his) – Gilead Sciences ### 1770984###Speaker###Executive Director, Clinical Pharmacology###Gilead Sciences###Speaker: Sreeneeranj Kasichayanula, PhD (he/him/his) – Gilead Sciences
### he/him/his @@@ Michael A. Pacanowski, PharmD – US Food and Drug Administration ### 867604###Speaker######US Food and Drug Administration###Speaker: Michael A. Pacanowski, PharmD – US Food and Drug Administration
###Chair: Mohamed Shahin, PhD, MS – Pfizer, Inc.
Chair: James Lu, PhD – Genentech
Chair: C.J. Musante, PhD (she/her/hers) – Pfizer, Inc.
Chair: Gary Mo, PhD (he/him/his) – Eli Lilly and Company
Chair: Qi Liu, PhD – US Food and Drug Administration
Speaker: Yuanfang Guan, PhD – University of Michigan
Speaker: Subha Madhavan, PhD – Pfizer Inc.
Speaker: Qi Liu, PhD – US Food and Drug Administration
Speaker: James Lu, PhD – Genentech
Speaker: Jagdeep Podichetty, PhD – Critical Path Institute
Speaker: Jie Shen, PhD – AbbVie
Speaker: Lei Xie, PhD (he/him/his) – The City University of New York
Speaker: Sebastian Lobentanzer, PhD (he/him/his) – Heidelberg University Hospital
Speaker: Prashant Desai, PhD (he/him/his) – Genentech
Speaker: Wei Gao, PhD (she/her/hers) – EMD Serono
Speaker: Matthew Wiens (he/him/his) – Metrum Research Group, Tariffville, CT, USA
Speaker: Tomas Helikar, PhD – University of Nebraska - Lincoln
Speaker: Flora Musuamba Tshinanu, PhD (she/her/hers) – Federal Agency for Medicines and Health Products/ University of Namur
Speaker: Keunwoo Choi, PhD (he/him/his) – Genentech
Speaker: Jogarao Gobburu, MBA, PhD – University of Maryland
Speaker: Sirj Goswami, PhD – InsightRX
Speaker: Saskia N. de Wildt, MD, PhD – Radboud University Medical Center
Translational Informatics (TI)
Chair: Mohamed Shahin, PhD, MS – Pfizer, Inc.
### @@@ James Lu, PhD – Genentech ### 1143236###Chair###Distinguished AI Scientist, Clinical Pharmacology###Genentech###Chair: James Lu, PhD – Genentech
### @@@ C.J. Musante, PhD (she/her/hers) – Pfizer, Inc. ### 2121892###Chair###Vice President of Scientific Research and Global Head of Pharmacometrics and Systems Pharmacology###Pfizer, Inc.###Chair: C.J. Musante, PhD (she/her/hers) – Pfizer, Inc.
### she/her/hers @@@ Gary Mo, PhD (he/him/his) – Eli Lilly and Company ### 2172852###Chair###Director - Global PK/PD and Pharmacometrics###Eli Lilly and Company###Chair: Gary Mo, PhD (he/him/his) – Eli Lilly and Company
### he/him/his @@@ Qi Liu, PhD – US Food and Drug Administration ### 867595###Chair###Associate Director for Innovation & Partnership, Office of Clinical Pharmacology###US Food and Drug Administration###Chair: Qi Liu, PhD – US Food and Drug Administration
### @@@ Yuanfang Guan, PhD – University of Michigan ### 1186965###Speaker###Associate Professor###University of Michigan###Speaker: Yuanfang Guan, PhD – University of Michigan
### @@@ Subha Madhavan, PhD – Pfizer Inc. ### 2121893###Speaker######Pfizer Inc.###Speaker: Subha Madhavan, PhD – Pfizer Inc.
### @@@ Qi Liu, PhD – US Food and Drug Administration ### 867595###Speaker###Associate Director for Innovation & Partnership, Office of Clinical Pharmacology###US Food and Drug Administration###Speaker: Qi Liu, PhD – US Food and Drug Administration
### @@@ James Lu, PhD – Genentech ### 1143236###Speaker###Distinguished AI Scientist, Clinical Pharmacology###Genentech###Speaker: James Lu, PhD – Genentech
### @@@ Jagdeep Podichetty, PhD – Critical Path Institute ### 1429068###Speaker###Senior Director, Predictive Analytics###Critical Path Institute###Speaker: Jagdeep Podichetty, PhD – Critical Path Institute
### @@@ Jie Shen, PhD – AbbVie ### 2188231###Speaker###Director###AbbVie###Speaker: Jie Shen, PhD – AbbVie
### @@@ Lei Xie, PhD (he/him/his) – The City University of New York ### 2248307###Speaker###Professor###The City University of New York###Speaker: Lei Xie, PhD (he/him/his) – The City University of New York
### he/him/his @@@ Sebastian Lobentanzer, PhD (he/him/his) – Heidelberg University Hospital ### 2188226###Speaker###Knowledge Representation Research Area Lead###Heidelberg University Hospital###Speaker: Sebastian Lobentanzer, PhD (he/him/his) – Heidelberg University Hospital
### he/him/his @@@ Prashant Desai, PhD (he/him/his) – Genentech ### 2188232###Speaker###Distinguished Scientist###Genentech###Speaker: Prashant Desai, PhD (he/him/his) – Genentech
### he/him/his @@@ Wei Gao, PhD (she/her/hers) – EMD Serono ### 1819763###Speaker######EMD Serono###Speaker: Wei Gao, PhD (she/her/hers) – EMD Serono
### she/her/hers @@@ Matthew Wiens (he/him/his) – Metrum Research Group, Tariffville, CT, USA ### 2172414###Speaker###Senior Scientist###Metrum Research Group, Tariffville, CT, USA###Speaker: Matthew Wiens (he/him/his) – Metrum Research Group, Tariffville, CT, USA
### he/him/his @@@ Tomas Helikar, PhD – University of Nebraska - Lincoln ### 2188227###Speaker###Director, Digital Twin Innovation Hub; Professor###University of Nebraska - Lincoln###Speaker: Tomas Helikar, PhD – University of Nebraska - Lincoln
### @@@ Flora Musuamba Tshinanu, PhD (she/her/hers) – Federal Agency for Medicines and Health Products/ University of Namur ### 1649803###Speaker###Assessor/Professor###Federal Agency for Medicines and Health Products/ University of Namur###Speaker: Flora Musuamba Tshinanu, PhD (she/her/hers) – Federal Agency for Medicines and Health Products/ University of Namur
### she/her/hers @@@ Keunwoo Choi, PhD (he/him/his) – Genentech ### 2259844###Speaker###Principal ML Scientist###Genentech###Speaker: Keunwoo Choi, PhD (he/him/his) – Genentech
### he/him/his @@@ Jogarao Gobburu, MBA, PhD – University of Maryland ### 2230171###Speaker###Professor###University of Maryland###Speaker: Jogarao Gobburu, MBA, PhD – University of Maryland
### @@@ Sirj Goswami, PhD – InsightRX ### 2232217###Speaker###CEO###InsightRX###Speaker: Sirj Goswami, PhD – InsightRX
### @@@ Saskia N. de Wildt, MD, PhD – Radboud University Medical Center ### 1070942###Speaker###Professor of Clinical Pharmacology###Radboud University Medical Center###Speaker: Saskia N. de Wildt, MD, PhD – Radboud University Medical Center
###Chair: Walter Kraft, MD – Thomas Jefferson University
Award Recipient : Gilbert J. Burckart, PharmD – US Food and Drug Administration
Award Recipient: Amelia N. Deitchman, PharmD, PhD (she/her/hers) – University of California, San Francisco
Award Recipient: Piet H. van der Graaf, PharmD, PhD – Certara
Award Recipient: Susan Abdel-Rahman, PharmD – Health Data Synthesis Institute
Award Recipient: Larisa H. Cavallari, PharmD – University of Florida
Award Recipient: Sean Hennessy, PharmD, PhD – University of Pennsylvania
Chair: Walter Kraft, MD – Thomas Jefferson University
### @@@ Gilbert J. Burckart, PharmD – US Food and Drug Administration ### 1530161###Award Recipient ###Assoc Director for Pediatrics###US Food and Drug Administration###Award Recipient : Gilbert J. Burckart, PharmD – US Food and Drug Administration
### @@@ Amelia N. Deitchman, PharmD, PhD (she/her/hers) – University of California, San Francisco ### 2128780###Award Recipient######University of California, San Francisco###Award Recipient: Amelia N. Deitchman, PharmD, PhD (she/her/hers) – University of California, San Francisco
### she/her/hers @@@ Piet H. van der Graaf, PharmD, PhD – Certara ### 1485757###Award Recipient###Senior Vice President and Professor of Systems Pharmacology###Certara###Award Recipient: Piet H. van der Graaf, PharmD, PhD – Certara
### @@@ Susan Abdel-Rahman, PharmD – Health Data Synthesis Institute ### 1143916###Award Recipient######Health Data Synthesis Institute###Award Recipient: Susan Abdel-Rahman, PharmD – Health Data Synthesis Institute
### @@@ Larisa H. Cavallari, PharmD – University of Florida ### 867601###Award Recipient###Professor And Debbie DeSantis Term Professor###University of Florida###Award Recipient: Larisa H. Cavallari, PharmD – University of Florida
### @@@ Sean Hennessy, PharmD, PhD – University of Pennsylvania ### 1184386###Award Recipient######University of Pennsylvania###Award Recipient: Sean Hennessy, PharmD, PhD – University of Pennsylvania
###Award Lecturer: Catriona Waitt, PhD – University of Liverpool
Award Presenter: Walter Kraft, MD – Thomas Jefferson University
Pharmacometrics & Pharmacokinetics (PMK)
Special Populations (SPO)
Award Lecturer: Catriona Waitt, PhD – University of Liverpool
### @@@ Walter Kraft, MD – Thomas Jefferson University ### 1436017###Award Presenter###Professor###Thomas Jefferson University###Award Presenter: Walter Kraft, MD – Thomas Jefferson University
###Expert: Sandra A.G Visser, PhD – GlaxoSmithKline
Expert: Luana Pesco Koplowitz, MD, PhD – Duck Flats Pharma
Expert: Matthew Rizk, PhD (he/him/his) – Merck
Expert: Stephani L. Stancil, PhD (she/her/hers) – Children's Mercy Kansas City
Expert: Karen Rowland Yeo, PhD – Certara UK Ltd, Simcyp Division
Expert: Emily J. Cicali, PharmD – University of Florida
Expert: Neeraj Gupta, PhD (he/him/his) – Takeda Pharmaceuticals
Expert: Sandra A.G Visser, PhD – GlaxoSmithKline
### @@@ Luana Pesco Koplowitz, MD, PhD – Duck Flats Pharma ### 1256302###Expert######Duck Flats Pharma###Expert: Luana Pesco Koplowitz, MD, PhD – Duck Flats Pharma
### @@@ Matthew Rizk, PhD (he/him/his) – Merck ### 1481695###Expert###Executive Director, Quantitative Pharmacology and Pharmacometrics###Merck###Expert: Matthew Rizk, PhD (he/him/his) – Merck
### he/him/his @@@ Stephani L. Stancil, PhD (she/her/hers) – Children's Mercy Kansas City ### 1214019###Expert###Assistant Professor###Children's Mercy Kansas City###Expert: Stephani L. Stancil, PhD (she/her/hers) – Children's Mercy Kansas City
### she/her/hers @@@ Karen Rowland Yeo, PhD – Certara UK Ltd, Simcyp Division ### 1770944###Expert###SVP Client & Regulatory Strategy###Certara UK Ltd, Simcyp Division###Expert: Karen Rowland Yeo, PhD – Certara UK Ltd, Simcyp Division
### @@@ Emily J. Cicali, PharmD – University of Florida ### 1070973###Expert###Clinical Assistant Professor###University of Florida###Expert: Emily J. Cicali, PharmD – University of Florida
### @@@ Neeraj Gupta, PhD (he/him/his) – Takeda Pharmaceuticals ### 1143599###Expert###Executive Director, Quantitative Clinical Pharmacology###Takeda Pharmaceuticals###Expert: Neeraj Gupta, PhD (he/him/his) – Takeda Pharmaceuticals
### he/him/hisState of the Art Speaker: Kelly Chibale, PhD – H3D Research Centre, University of Cape Town
Moderator: Walter Kraft, MD – Thomas Jefferson University
Infectious Diseases (INF)
State of the Art Speaker: Kelly Chibale, PhD – H3D Research Centre, University of Cape Town
### @@@ Walter Kraft, MD – Thomas Jefferson University ### 1436017###Moderator###Professor###Thomas Jefferson University###Moderator: Walter Kraft, MD – Thomas Jefferson University
###Chair: Piet H. van der Graaf, PharmD, PhD – Certara
Chair: Kathleen M. Giacomini, PhD – University of California, San Francisco
Speaker: Henk-Jan Guchelaar, PharmD, PhD – Leiden University Medical Center
Speaker: David J. Greenblatt, MD (he/him/his) – Tufts University School of Medicine
Speaker: Karen E. Brown, PharmD – University of Montana
Speaker: Neil Hanchard, MD, PhD – National Institute of Health
Pharmacogenomics (PGx)
Special Populations (SPO)
Chair: Piet H. van der Graaf, PharmD, PhD – Certara
### @@@ Kathleen M. Giacomini, PhD – University of California, San Francisco ### 1429074###Chair###Professor and Dean, School of Pharmacy###University of California, San Francisco###Chair: Kathleen M. Giacomini, PhD – University of California, San Francisco
### @@@ Henk-Jan Guchelaar, PharmD, PhD – Leiden University Medical Center ### 1143253###Speaker###Professor###Leiden University Medical Center###Speaker: Henk-Jan Guchelaar, PharmD, PhD – Leiden University Medical Center
### @@@ David J. Greenblatt, MD (he/him/his) – Tufts University School of Medicine ### 1436029###Speaker###Professor###Tufts University School of Medicine###Speaker: David J. Greenblatt, MD (he/him/his) – Tufts University School of Medicine
### he/him/his @@@ Karen E. Brown, PharmD – University of Montana ### 1502602###Speaker###Principal Scientist###University of Montana###Speaker: Karen E. Brown, PharmD – University of Montana
### @@@ Neil Hanchard, MD, PhD – National Institute of Health ### 1429094###Speaker###Senior Investigator###National Institute of Health###Speaker: Neil Hanchard, MD, PhD – National Institute of Health
###Chair: Naomi Gronich, MD (she/her/hers) – Clalit Health Services, and Rappaport Faculty of Medicine, Technion - Israel Institue of Technology
Chair: Mohamed Elmeliegy, PhD, MBA – Pfizer, Inc.
Speaker: Linda Kalilani, MBBS, MPH, PhD – GlaxoSmithKline
Speaker: Emily Bratton, PhD (she/her/hers) – IQVIA
Speaker: Elisabetta Patorno, MD, PhD – Harvard Medical School
Drug Utilization & Outcomes (DUO)
Life Cycle Management (LCM)
Chair: Naomi Gronich, MD (she/her/hers) – Clalit Health Services, and Rappaport Faculty of Medicine, Technion - Israel Institue of Technology
### she/her/hers @@@ Mohamed Elmeliegy, PhD, MBA – Pfizer, Inc. ### 2130797###Chair###Director, Oncology Clinical Pharmacology###Pfizer, Inc.###Chair: Mohamed Elmeliegy, PhD, MBA – Pfizer, Inc.
### @@@ Linda Kalilani, MBBS, MPH, PhD – GlaxoSmithKline ### 2121854###Speaker###Senior Director & Head of Oncology Epidemiology ###GlaxoSmithKline###Speaker: Linda Kalilani, MBBS, MPH, PhD – GlaxoSmithKline
### @@@ Emily Bratton, PhD (she/her/hers) – IQVIA ### 2121855###Speaker###Category Lead, Real World Solutions###IQVIA###Speaker: Emily Bratton, PhD (she/her/hers) – IQVIA
### she/her/hers @@@ Elisabetta Patorno, MD, PhD – Harvard Medical School ### 2121857###Speaker###Associate Professor of Medicine###Harvard Medical School###Speaker: Elisabetta Patorno, MD, PhD – Harvard Medical School
###Chair: Sook Wah Yee, PhD – University of California, San Francisco
Chair: Kit Wun Kathy Cheung, PharmD (she/her/hers) – Genentech
Speaker: Vikram Arya, PhD (he/him/his) – US Food and Drug Administration
Speaker: Jashvant D. Unadkat, PhD (he/him/his) – University of Washington
Speaker: Sibylle Neuhoff, PhD (she/her/hers) – Certara UK (Simcyp Division)
Membrane Transporter (MT)
Physiological Based Pharmacokinetic Modeling and Simulation (PBPK)
Chair: Sook Wah Yee, PhD – University of California, San Francisco
### @@@ Kit Wun Kathy Cheung, PharmD (she/her/hers) – Genentech ### 1770961###Chair###Principal Scientist, Clinical Pharmacology###Genentech###Chair: Kit Wun Kathy Cheung, PharmD (she/her/hers) – Genentech
### she/her/hers @@@ Vikram Arya, PhD (he/him/his) – US Food and Drug Administration ### 1429056###Speaker###Associate Director for Therapeutic Review (ADTR)###US Food and Drug Administration###Speaker: Vikram Arya, PhD (he/him/his) – US Food and Drug Administration
### he/him/his @@@ Jashvant D. Unadkat, PhD (he/him/his) – University of Washington ### 2121880###Speaker###Professor###University of Washington###Speaker: Jashvant D. Unadkat, PhD (he/him/his) – University of Washington
### he/him/his @@@ Sibylle Neuhoff, PhD (she/her/hers) – Certara UK (Simcyp Division) ### 1187891###Speaker###Senior Scientific Adviser###Certara UK (Simcyp Division)###Speaker: Sibylle Neuhoff, PhD (she/her/hers) – Certara UK (Simcyp Division)
### she/her/hersPartner Presenter: Aernout D. van Haarst, PhD (he/him/his) – Celerion
Partner Presenter: Aernout D. van Haarst, PhD (he/him/his) – Celerion
### he/him/hisPartner Presenter: Angela Qu, MD, PhD (she/her/hers) – Parexel
Partner Presenter: Ana Novakovic – Parexel International
Partner Presenter: Angela Qu, MD, PhD (she/her/hers) – Parexel
### she/her/hers @@@ Ana Novakovic – Parexel International ### 1819430###Partner Presenter######Parexel International###Partner Presenter: Ana Novakovic – Parexel International
###Expert: Abigail Gorman
Expert: Mohamed Shahin, PhD, MS – Pfizer, Inc.
Expert: Abigail Gorman
### @@@ Mohamed Shahin, PhD, MS – Pfizer, Inc. ### 1819280###Expert###Clinical Pharmacologist###Pfizer, Inc.###Expert: Mohamed Shahin, PhD, MS – Pfizer, Inc.
###Partner Presenter: Jocelyn Courville, MBA, MS, PhD – ICON
Partner Presenter: Jocelyn Courville, MBA, MS, PhD – ICON
###Featured Speaker: Kelly E. Dooley, MD, MPH, PhD (she/her/hers) – Vanderbilt University Medical Center
Moderator: Walter Kraft, MD – Thomas Jefferson University
Featured Speaker: Kelly E. Dooley, MD, MPH, PhD (she/her/hers) – Vanderbilt University Medical Center
### she/her/hers @@@ Walter Kraft, MD – Thomas Jefferson University ### 1436017###Moderator###Professor###Thomas Jefferson University###Moderator: Walter Kraft, MD – Thomas Jefferson University
###Award Lecturer: Gauri G. Rao, PharmD (she/her/hers) – University of Southern California
Award Presenter: Kim Brouwer, PharmD, PhD – University of North Carolina at Chapel Hill
Infectious Diseases (INF)
Systems Pharmacology (SP)
Award Lecturer: Gauri G. Rao, PharmD (she/her/hers) – University of Southern California
### she/her/hers @@@ Kim Brouwer, PharmD, PhD – University of North Carolina at Chapel Hill ### 830449###Award Presenter###Associate Dean for Research and Graduate Education UNC Eshelman School of Pharmacy###University of North Carolina at Chapel Hill###Award Presenter: Kim Brouwer, PharmD, PhD – University of North Carolina at Chapel Hill
###Chair: Kyunghee Yang, PhD (she/her/hers) – Simulations Plus
Chair: Daniel Gonzalez, PharmD, PhD (he/him/his) – Duke University
Speaker: Qi Liu, PhD – US Food and Drug Administration
Speaker: Jeffrey L. Woodhead, PhD (he/him/his) – Simulations Plus
Speaker: Murali Ramanathan, PhD (he/him/his) – University at Buffalo
Systems Pharmacology (SP)
Special Populations (SPO)
Chair: Kyunghee Yang, PhD (she/her/hers) – Simulations Plus
### she/her/hers @@@ Daniel Gonzalez, PharmD, PhD (he/him/his) – Duke University ### 2121860###Chair###Instructor###Duke University###Chair: Daniel Gonzalez, PharmD, PhD (he/him/his) – Duke University
### he/him/his @@@ Qi Liu, PhD – US Food and Drug Administration ### 867595###Speaker###Associate Director for Innovation & Partnership, Office of Clinical Pharmacology###US Food and Drug Administration###Speaker: Qi Liu, PhD – US Food and Drug Administration
### @@@ Jeffrey L. Woodhead, PhD (he/him/his) – Simulations Plus ### 2121861###Speaker###Senior Principal Scientist###Simulations Plus###Speaker: Jeffrey L. Woodhead, PhD (he/him/his) – Simulations Plus
### he/him/his @@@ Murali Ramanathan, PhD (he/him/his) – University at Buffalo ### 2121862###Speaker###Professor###University at Buffalo###Speaker: Murali Ramanathan, PhD (he/him/his) – University at Buffalo
### he/him/hisChair: Nithya Srinivas, PhD (she/her/hers) – Mind Medicine
Chair: Stephani L. Stancil, PhD (she/her/hers) – Children's Mercy Kansas City
Speaker: Jeffrey Robert Strawn, MD (he/him/his) – University of Cincinnati
Speaker: Stephani L. Stancil, PhD (she/her/hers) – Children's Mercy Kansas City
Speaker: Arjun Athreya, PhD, MSc – Mayo Clinic
Speaker: Erica L. Woodahl, PhD (she/her/hers) – University of Montana
Mental Health & Addiction (MHA)
Early Career (EC)
Chair: Nithya Srinivas, PhD (she/her/hers) – Mind Medicine
### she/her/hers @@@ Stephani L. Stancil, PhD (she/her/hers) – Children's Mercy Kansas City ### 1214019###Chair###Assistant Professor###Children's Mercy Kansas City###Chair: Stephani L. Stancil, PhD (she/her/hers) – Children's Mercy Kansas City
### she/her/hers @@@ Jeffrey Robert Strawn, MD (he/him/his) – University of Cincinnati ### 1144053###Speaker###Professor of Psychiatry###University of Cincinnati###Speaker: Jeffrey Robert Strawn, MD (he/him/his) – University of Cincinnati
### he/him/his @@@ Stephani L. Stancil, PhD (she/her/hers) – Children's Mercy Kansas City ### 1214019###Speaker###Assistant Professor###Children's Mercy Kansas City###Speaker: Stephani L. Stancil, PhD (she/her/hers) – Children's Mercy Kansas City
### she/her/hers @@@ Arjun Athreya, PhD, MSc – Mayo Clinic ### 2121849###Speaker###Assistant Professor of Pharmacology & Psychiatry###Mayo Clinic###Speaker: Arjun Athreya, PhD, MSc – Mayo Clinic
### @@@ Erica L. Woodahl, PhD (she/her/hers) – University of Montana ### 1144011###Speaker###Professor###University of Montana###Speaker: Erica L. Woodahl, PhD (she/her/hers) – University of Montana
### she/her/hersPartner Presenter: Amy Cheung, PhD (she/her/hers) – Certara
Partner Presenter: Mark Shelton, PharmD – Certara Drug Development Solutions
Partner Presenter: Amy Cheung, PhD (she/her/hers) – Certara
### she/her/hers @@@ Mark Shelton, PharmD – Certara Drug Development Solutions ### 2275982###Partner Presenter###Senior Director###Certara Drug Development Solutions###Partner Presenter: Mark Shelton, PharmD – Certara Drug Development Solutions
###Partner Presenter: Geert Jan Groeneveld
Partner Presenter: Koos Burggraaf, PhD – Centre for Human Drug Research
Partner Presenter: Robert Rissman
Partner Presenter: Geert Jan Groeneveld
### @@@ Koos Burggraaf, PhD – Centre for Human Drug Research ### 2288219###Partner Presenter######Centre for Human Drug Research###Partner Presenter: Koos Burggraaf, PhD – Centre for Human Drug Research
### @@@ Robert Rissman ### 2288220###Partner Presenter#########Partner Presenter: Robert Rissman
###Chair: Naomi Gronich, MD (she/her/hers) – Clalit Health Services, and Rappaport Faculty of Medicine, Technion - Israel Institue of Technology
Chair: Mohamed Elmeliegy, PhD, MBA – Pfizer, Inc.
Speaker: Linda Kalilani, MBBS, MPH, PhD – GlaxoSmithKline
Speaker: Emily Bratton, PhD (she/her/hers) – IQVIA
Speaker: Elisabetta Patorno, MD, PhD – Harvard Medical School
Drug Utilization & Outcomes (DUO)
Life Cycle Management (LCM)
Chair: Naomi Gronich, MD (she/her/hers) – Clalit Health Services, and Rappaport Faculty of Medicine, Technion - Israel Institue of Technology
### she/her/hers @@@ Mohamed Elmeliegy, PhD, MBA – Pfizer, Inc. ### 2130797###Chair###Director, Oncology Clinical Pharmacology###Pfizer, Inc.###Chair: Mohamed Elmeliegy, PhD, MBA – Pfizer, Inc.
### @@@ Linda Kalilani, MBBS, MPH, PhD – GlaxoSmithKline ### 2121854###Speaker###Senior Director & Head of Oncology Epidemiology ###GlaxoSmithKline###Speaker: Linda Kalilani, MBBS, MPH, PhD – GlaxoSmithKline
### @@@ Emily Bratton, PhD (she/her/hers) – IQVIA ### 2121855###Speaker###Category Lead, Real World Solutions###IQVIA###Speaker: Emily Bratton, PhD (she/her/hers) – IQVIA
### she/her/hers @@@ Elisabetta Patorno, MD, PhD – Harvard Medical School ### 2121857###Speaker###Associate Professor of Medicine###Harvard Medical School###Speaker: Elisabetta Patorno, MD, PhD – Harvard Medical School
###Chair: John Wagner, MD, PhD (he/him/his) – Koneksa Health
Speaker: Diane Stephenson, PhD – Critical Path Institute
Speaker: Sarah Zenner-Dolan (she/her/hers) – Critical Path For Parkinson's
Speaker: Qi Liu, PhD – US Food and Drug Administration
Speaker: Peter Schmidt, PhD (he/him/his) – Rho, Inc.
Chair: John Wagner, MD, PhD (he/him/his) – Koneksa Health
### he/him/his @@@ Diane Stephenson, PhD – Critical Path Institute ### 1429065###Speaker###Executive Director###Critical Path Institute###Speaker: Diane Stephenson, PhD – Critical Path Institute
### @@@ Sarah Zenner-Dolan (she/her/hers) – Critical Path For Parkinson's ### 2173787###Speaker###Patient###Critical Path For Parkinson's###Speaker: Sarah Zenner-Dolan (she/her/hers) – Critical Path For Parkinson's
### she/her/hers @@@ Qi Liu, PhD – US Food and Drug Administration ### 867595###Speaker###Associate Director for Innovation & Partnership, Office of Clinical Pharmacology###US Food and Drug Administration###Speaker: Qi Liu, PhD – US Food and Drug Administration
### @@@ Peter Schmidt, PhD (he/him/his) – Rho, Inc. ### 2236082###Speaker###Chief Scientific Officer###Rho, Inc.###Speaker: Peter Schmidt, PhD (he/him/his) – Rho, Inc.
### he/him/hisPartner Presenter: Oren Cohen, MD – Fortrea
Partner Presenter: Oren Cohen, MD – Fortrea
###Expert: Jing Liu, PhD (she/her/hers) – Pfizer, Inc.
Expert: Daniele Ouellet, PhD – Johnson & Johnson
Expert: Jing Liu, PhD (she/her/hers) – Pfizer, Inc.
### she/her/hers @@@ Daniele Ouellet, PhD – Johnson & Johnson ### 1429066###Expert###Global Head Clinical Pharmacology & Pharmacometrics###Johnson & Johnson###Expert: Daniele Ouellet, PhD – Johnson & Johnson
###Award Lecturer: Zhu Zhou, PhD (she/her/hers) – City University of New York
Award Presenter: Mary Paine, PhD, RPh – Washington State University
Physiological Based Pharmacokinetic Modeling and Simulation (PBPK)
Special Populations (SPO)
Award Lecturer: Zhu Zhou, PhD (she/her/hers) – City University of New York
### she/her/hers @@@ Mary Paine, PhD, RPh – Washington State University ### 1818844###Award Presenter###Professor###Washington State University###Award Presenter: Mary Paine, PhD, RPh – Washington State University
###Award Lecturer: Amy H. Racine-Poon, PhD – Novartis Pharma AG
Award Presenter: Steven E. Kern, PhD (he/him/his) – Global Health Labs
Pharmacometrics & Pharmacokinetics (PMK)
Award Lecturer: Amy H. Racine-Poon, PhD – Novartis Pharma AG
### @@@ Steven E. Kern, PhD (he/him/his) – Global Health Labs ### 1178577###Award Presenter###Executive Director###Global Health Labs###Award Presenter: Steven E. Kern, PhD (he/him/his) – Global Health Labs
### he/him/hisChair: Jagdeep Podichetty, PhD – Critical Path Institute
Chair: Jamie Connarn, PhD – Amgen
Speaker: Fuensanta Bellvís Bataller, MSc (she/her/hers) – Quibim
Speaker: Sarah Kim, PhD (she/her/hers) – University of Florida
Speaker: Yuanfang Guan, PhD – University of Michigan
Pharmacometrics & Pharmacokinetics (PMK)
Translational Informatics (TI)
Chair: Jagdeep Podichetty, PhD – Critical Path Institute
### @@@ Jamie Connarn, PhD – Amgen ### 2278279###Chair###Senior Principal Scientist###Amgen###Chair: Jamie Connarn, PhD – Amgen
### @@@ Fuensanta Bellvís Bataller, MSc (she/her/hers) – Quibim ### 2273456###Speaker###VP of Clinical Studies###Quibim###Speaker: Fuensanta Bellvís Bataller, MSc (she/her/hers) – Quibim
### she/her/hers @@@ Sarah Kim, PhD (she/her/hers) – University of Florida ### 1818861###Speaker###Assistant Professor###University of Florida###Speaker: Sarah Kim, PhD (she/her/hers) – University of Florida
### she/her/hers @@@ Yuanfang Guan, PhD – University of Michigan ### 1186965###Speaker###Associate Professor###University of Michigan###Speaker: Yuanfang Guan, PhD – University of Michigan
###Chair: Daniel Gonzalez, PharmD, PhD (he/him/his) – Duke University
Chair: Elimika P. Pfuma Fletcher, PharmD, PhD (he/him/his) – US Food and Drug Administration
Chair: Daniel Gonzalez, PharmD, PhD (he/him/his) – Duke University
### he/him/his @@@ Elimika P. Pfuma Fletcher, PharmD, PhD (he/him/his) – US Food and Drug Administration ### 1819017###Chair###Policy Lead###US Food and Drug Administration###Chair: Elimika P. Pfuma Fletcher, PharmD, PhD (he/him/his) – US Food and Drug Administration
### he/him/hisExpert: Kathryn Momary-Carter, PharmD (she/her/hers) – Merck & Co.
Expert: Lisa Benincosa – EMD Serono
Expert: Shayna R. Killam, MS, PharmD (she/her/hers) – University of Montana
Expert: Georgios Vlasakakis, PhD (he/him/his) – GlaxoSmithKline
Expert: Dan Hartman, MD (he/him/his) – Bill & Melinda Gates Foundation
Expert: Walter Kraft, MD – Thomas Jefferson University
Expert: Kathryn Momary-Carter, PharmD (she/her/hers) – Merck & Co.
### she/her/hers @@@ Lisa Benincosa – EMD Serono ### 1819331###Expert######EMD Serono###Expert: Lisa Benincosa – EMD Serono
### @@@ Shayna R. Killam, MS, PharmD (she/her/hers) – University of Montana ### 1143999###Expert###Postdoctoral Fellow###University of Montana###Expert: Shayna R. Killam, MS, PharmD (she/her/hers) – University of Montana
### she/her/hers @@@ Georgios Vlasakakis, PhD (he/him/his) – GlaxoSmithKline ### 1307126###Expert###Director Clinical Pharmacology###GlaxoSmithKline###Expert: Georgios Vlasakakis, PhD (he/him/his) – GlaxoSmithKline
### he/him/his @@@ Dan Hartman, MD (he/him/his) – Bill & Melinda Gates Foundation ### 949850###Expert###Director, Integrated Development; Global Health###Bill & Melinda Gates Foundation###Expert: Dan Hartman, MD (he/him/his) – Bill & Melinda Gates Foundation
### he/him/his @@@ Walter Kraft, MD – Thomas Jefferson University ### 1436017###Expert###Professor###Thomas Jefferson University###Expert: Walter Kraft, MD – Thomas Jefferson University
###Chair: Matthew McLaughlin, MD – Children's Mercy - Kansas City
Chair: Melanie Nicol, PharmD, PhD (she/her/hers) – University of Minnesota
Chair: Matthew McLaughlin, MD – Children's Mercy - Kansas City
### @@@ Melanie Nicol, PharmD, PhD (she/her/hers) – University of Minnesota ### 851988###Chair###Associate Professor###University of Minnesota###Chair: Melanie Nicol, PharmD, PhD (she/her/hers) – University of Minnesota
### she/her/hersChair: Angela J. James, PhD, MS (she/her/hers) – iTeos Therapeutics
Chair: Joseph Chen, PharmD – Genentech
Chair: Angela J. James, PhD, MS (she/her/hers) – iTeos Therapeutics
### she/her/hers @@@ Joseph Chen, PharmD – Genentech ### 1070921###Chair###Senior Principal Scientist###Genentech###Chair: Joseph Chen, PharmD – Genentech
###Featured Speaker: Karthik Venkatakrishnan, PhD (he/him/his) – EMD Serono
Moderator: Matthew Rizk, PhD (he/him/his) – Merck
Pharmacometrics & Pharmacokinetics (PMK)
Oncology (ONC)
Featured Speaker: Karthik Venkatakrishnan, PhD (he/him/his) – EMD Serono
### he/him/his @@@ Matthew Rizk, PhD (he/him/his) – Merck ### 1481695###Moderator###Executive Director, Quantitative Pharmacology and Pharmacometrics###Merck###Moderator: Matthew Rizk, PhD (he/him/his) – Merck
### he/him/hisChair: Mohamed Shahin, PhD, MS – Pfizer, Inc.
Chair: Shuhan Liu (she/her/hers) – University of Michigan
Speaker: Sharon J. Swan, MBA (she/her/hers) – ASCPT
Speaker: Karen Rowland Yeo, PhD – Certara UK Ltd, Simcyp Division
Speaker: Anuradha Ramamoorthy, PhD – Potomac, MD
Speaker: Shayna R. Killam, MS, PharmD (she/her/hers) – University of Montana
Student & Trainee (ST)
Translational Informatics (TI)
Chair: Mohamed Shahin, PhD, MS – Pfizer, Inc.
### @@@ Shuhan Liu (she/her/hers) – University of Michigan ### 2172604###Chair###Graduate student###University of Michigan###Chair: Shuhan Liu (she/her/hers) – University of Michigan
### she/her/hers @@@ Sharon J. Swan, MBA (she/her/hers) – ASCPT ### 1256287###Speaker###CEO Emeritus###ASCPT###Speaker: Sharon J. Swan, MBA (she/her/hers) – ASCPT
### she/her/hers @@@ Karen Rowland Yeo, PhD – Certara UK Ltd, Simcyp Division ### 1770944###Speaker###SVP Client & Regulatory Strategy###Certara UK Ltd, Simcyp Division###Speaker: Karen Rowland Yeo, PhD – Certara UK Ltd, Simcyp Division
### @@@ Anuradha Ramamoorthy, PhD – Potomac, MD ### 1156653###Speaker######Potomac, MD###Speaker: Anuradha Ramamoorthy, PhD – Potomac, MD
### @@@ Shayna R. Killam, MS, PharmD (she/her/hers) – University of Montana ### 1143999###Speaker###Postdoctoral Fellow###University of Montana###Speaker: Shayna R. Killam, MS, PharmD (she/her/hers) – University of Montana
### she/her/hersChair: Amy Cheung, PhD (she/her/hers) – Certara
Chair: Lionel Tan, MBBS, PhD (he/him/his) – ViiV
Speaker: Cindy H. Brothers, MPH (she/her/hers) – ViiV Healthcare
Speaker: Jennifer J. Kiser, PharmD, PhD (she/her/hers) – Merck Research Labs
Speaker: Melynda Watkins (she/her/hers) – Clinton Health Access Initiative (CHAI)
Speaker: Elizabeth J. McFarland, MD (she/her/hers) – University of Colorado School of Medicine
Global Health (GH)
Infectious Diseases (INF)
Chair: Amy Cheung, PhD (she/her/hers) – Certara
### she/her/hers @@@ Lionel Tan, MBBS, PhD (he/him/his) – ViiV ### 2121884###Chair###Medicine Development Lead, Paediatric HIV###ViiV###Chair: Lionel Tan, MBBS, PhD (he/him/his) – ViiV
### he/him/his @@@ Cindy H. Brothers, MPH (she/her/hers) – ViiV Healthcare ### 2219661###Speaker###Senior Director, Pediatric Clinical Development###ViiV Healthcare###Speaker: Cindy H. Brothers, MPH (she/her/hers) – ViiV Healthcare
### she/her/hers @@@ Jennifer J. Kiser, PharmD, PhD (she/her/hers) – Merck Research Labs ### 1819335###Speaker###Regional Medical Scientific Director - Virology###Merck Research Labs###Speaker: Jennifer J. Kiser, PharmD, PhD (she/her/hers) – Merck Research Labs
### she/her/hers @@@ Melynda Watkins (she/her/hers) – Clinton Health Access Initiative (CHAI) ### 2230149###Speaker###Senior Director, Product development, Quality, Costing, and Regulatory Affairs###Clinton Health Access Initiative (CHAI)###Speaker: Melynda Watkins (she/her/hers) – Clinton Health Access Initiative (CHAI)
### she/her/hers @@@ Elizabeth J. McFarland, MD (she/her/hers) – University of Colorado School of Medicine ### 2235993###Speaker###Professor of Pediatrics and Section Head, Pediatric Infectious Diseases and Epidemiology###University of Colorado School of Medicine###Speaker: Elizabeth J. McFarland, MD (she/her/hers) – University of Colorado School of Medicine
### she/her/hersState of the Art Speaker: Delali Attiogbe Attipoe, MBA (she/her/hers) – DNDi
Moderator: Karen Rowland Yeo, PhD – Certara UK Ltd, Simcyp Division
Global Health (GH)
Drug Utilization & Outcomes (DUO)
State of the Art Speaker: Delali Attiogbe Attipoe, MBA (she/her/hers) – DNDi
### she/her/hers @@@ Karen Rowland Yeo, PhD – Certara UK Ltd, Simcyp Division ### 1770944###Moderator###SVP Client & Regulatory Strategy###Certara UK Ltd, Simcyp Division###Moderator: Karen Rowland Yeo, PhD – Certara UK Ltd, Simcyp Division
###Partner Presenter: Aernout D. van Haarst, PhD (he/him/his) – Celerion
Partner Presenter: Aernout D. van Haarst, PhD (he/him/his) – Celerion
### he/him/hisExpert: Abigail Gorman
Expert: Issam Zineh, MPH, PharmD – U.S. Food and Drug Administration
Expert: Antoinette Ajavon-Hartmann, PhD (she/her/hers) – Bristol Myers Squibb
Expert: Abigail Gorman
### @@@ Issam Zineh, MPH, PharmD – U.S. Food and Drug Administration ### 1770959###Expert###Director, Office of Clinical Pharmacology###U.S. Food and Drug Administration###Expert: Issam Zineh, MPH, PharmD – U.S. Food and Drug Administration
### @@@ Antoinette Ajavon-Hartmann, PhD (she/her/hers) – Bristol Myers Squibb ### 1201152###Expert###Associate Director###Bristol Myers Squibb###Expert: Antoinette Ajavon-Hartmann, PhD (she/her/hers) – Bristol Myers Squibb
### she/her/hersPartner Presenter: Jocelyn Courville, MBA, MS, PhD – ICON
Partner Presenter: Jocelyn Courville, MBA, MS, PhD – ICON
###Award Lecturer: Kathleen M. Giacomini, PhD – University of California, San Francisco
Award Presenter: Mark Dresser, PhD (he/him/his) – Gilead Sciences
Membrane Transporter (MT)
Pharmacogenomics (PGx)
Award Lecturer: Kathleen M. Giacomini, PhD – University of California, San Francisco
### @@@ Mark Dresser, PhD (he/him/his) – Gilead Sciences ### 956032###Award Presenter###Senior Vice President###Gilead Sciences###Award Presenter: Mark Dresser, PhD (he/him/his) – Gilead Sciences
### he/him/hisChair: Brian Cicali, PhD – Univ of Florida Coll of Pharmacy
Speaker: Paul Liang (he/him/his) – Carnegie Mellon University
Speaker: Wesley Anderson, PhD – Critical Path Institute
Speaker: Liang Zhao, PhD, MBA – US Food and Drug Administration
Drug Utilization & Outcomes (DUO)
Translational Informatics (TI)
Chair: Brian Cicali, PhD – Univ of Florida Coll of Pharmacy
### @@@ Paul Liang (he/him/his) – Carnegie Mellon University ### 2121863###Speaker###PhD student###Carnegie Mellon University###Speaker: Paul Liang (he/him/his) – Carnegie Mellon University
### he/him/his @@@ Wesley Anderson, PhD – Critical Path Institute ### 2121864###Speaker###Quantitative Medicine Scientist###Critical Path Institute###Speaker: Wesley Anderson, PhD – Critical Path Institute
### @@@ Liang Zhao, PhD, MBA – US Food and Drug Administration ### 1143392###Speaker###Division Director###US Food and Drug Administration###Speaker: Liang Zhao, PhD, MBA – US Food and Drug Administration
###Chair: Ted Grasela, PharmD, PhD – Azimuth Global Health Consulting
Chair: David Wesche, MD, PhD – Certara
Speaker: Dan Hartman, MD (he/him/his) – Bill & Melinda Gates Foundation
Speaker: Shirley Seo, PhD (she/her/hers) – US Food and Drug Administration
Speaker: Helen Byomire Ndagije, PhD (she/her/hers) – National Drug Authority
Speaker: Jackson Mukonzo, PhD, MSc – Makerere University
Global Health (GH)
Regulatory Science (RS)
Chair: Ted Grasela, PharmD, PhD – Azimuth Global Health Consulting
### @@@ David Wesche, MD, PhD – Certara ### 2121871###Chair######Certara###Chair: David Wesche, MD, PhD – Certara
### @@@ Dan Hartman, MD (he/him/his) – Bill & Melinda Gates Foundation ### 949850###Speaker###Director, Integrated Development; Global Health###Bill & Melinda Gates Foundation###Speaker: Dan Hartman, MD (he/him/his) – Bill & Melinda Gates Foundation
### he/him/his @@@ Shirley Seo, PhD (she/her/hers) – US Food and Drug Administration ### 1143504###Speaker###Director, Division of Cardiometabolic and Endocrine Pharmacology###US Food and Drug Administration###Speaker: Shirley Seo, PhD (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Helen Byomire Ndagije, PhD (she/her/hers) – National Drug Authority ### 2121873###Speaker###Director Product Safety###National Drug Authority###Speaker: Helen Byomire Ndagije, PhD (she/her/hers) – National Drug Authority
### she/her/hers @@@ Jackson Mukonzo, PhD, MSc – Makerere University ### 2121872###Speaker###Associate Professor & Chair Pharmacology & Therarpeutics Department###Makerere University###Speaker: Jackson Mukonzo, PhD, MSc – Makerere University
###Chair: Lei Zhang, PhD – US Food and Drug Administration
Chair: John Wagner, MD, PhD (he/him/his) – Koneksa Health
Speaker: Janice Schwartz, MD – University of California, San Francisco
Speaker: James Kirkland, MD, PhD (he/him/his) – Mayo Clinic
Speaker: John Wagner, MD, PhD (he/him/his) – Koneksa Health
Speaker: Mary Thanh Hai, MD – FDA/CDER/Office of New Drugs
Regulatory Science (RS)
Special Populations (SPO)
Chair: Lei Zhang, PhD – US Food and Drug Administration
### @@@ John Wagner, MD, PhD (he/him/his) – Koneksa Health ### 1201986###Chair###Chief Medical Officer###Koneksa Health###Chair: John Wagner, MD, PhD (he/him/his) – Koneksa Health
### he/him/his @@@ Janice Schwartz, MD – University of California, San Francisco ### 1429078###Speaker###Professor###University of California, San Francisco###Speaker: Janice Schwartz, MD – University of California, San Francisco
### @@@ James Kirkland, MD, PhD (he/him/his) – Mayo Clinic ### 2121853###Speaker######Mayo Clinic###Speaker: James Kirkland, MD, PhD (he/him/his) – Mayo Clinic
### he/him/his @@@ John Wagner, MD, PhD (he/him/his) – Koneksa Health ### 1201986###Speaker###Chief Medical Officer###Koneksa Health###Speaker: John Wagner, MD, PhD (he/him/his) – Koneksa Health
### he/him/his @@@ Mary Thanh Hai, MD – FDA/CDER/Office of New Drugs ### 2229070###Speaker###Deputy Director for Clinical Science###FDA/CDER/Office of New Drugs###Speaker: Mary Thanh Hai, MD – FDA/CDER/Office of New Drugs
###Partner Presenter: Piet H. van der Graaf, PharmD, PhD – Certara
Partner Presenter: John Burke – Applied BioMath
Partner Presenter: Fei Hua – Applied BioMath
Partner Presenter: Piet H. van der Graaf, PharmD, PhD – Certara
### @@@ John Burke – Applied BioMath ### 2276009###Partner Presenter###Co-Founder and the President and CEO###Applied BioMath###Partner Presenter: John Burke – Applied BioMath
### @@@ Fei Hua – Applied BioMath ### 2276084###Partner Presenter###VP Modeling and Simulation Services###Applied BioMath###Partner Presenter: Fei Hua – Applied BioMath
###Partner Presenter: Lona Sheeran, BS – Worldwide Clinical Trials
Partner Presenter: Lona Sheeran, BS – Worldwide Clinical Trials
###Award Lecturer: Kim Brouwer, PharmD, PhD – University of North Carolina at Chapel Hill
Award Presenter: Paul Watkins, MD (he/him/his) – University of North Carolina at Chapel Hill
Early Development & Drug Safety (EDDS)
Membrane Transporter (MT)
Award Lecturer: Kim Brouwer, PharmD, PhD – University of North Carolina at Chapel Hill
### @@@ Paul Watkins, MD (he/him/his) – University of North Carolina at Chapel Hill ### 1819252###Award Presenter###Professor###University of North Carolina at Chapel Hill###Award Presenter: Paul Watkins, MD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/hisChair: Ravi Shankar P. Singh, PhD (he/him/his) – Pfizer
Chair: Neeraj Gupta, PhD (he/him/his) – Takeda Pharmaceuticals
Speaker: Akintunde Bello, PhD (he/him/his) – Bristol Myers Squibb
Speaker: Amita Joshi, PhD (she/her/hers) – Genentech
Speaker: Adeniyi Olagunju, PhD (he/him/his) – University of Liverpool
Early Career (EC)
Student & Trainee (ST)
Chair: Ravi Shankar P. Singh, PhD (he/him/his) – Pfizer
### he/him/his @@@ Neeraj Gupta, PhD (he/him/his) – Takeda Pharmaceuticals ### 1143599###Chair###Executive Director, Quantitative Clinical Pharmacology###Takeda Pharmaceuticals###Chair: Neeraj Gupta, PhD (he/him/his) – Takeda Pharmaceuticals
### he/him/his @@@ Akintunde Bello, PhD (he/him/his) – Bristol Myers Squibb ### 2121875###Speaker###Senior Vice President Clinical Pharmacology, Pharmacometrics & Bioanalysis###Bristol Myers Squibb###Speaker: Akintunde Bello, PhD (he/him/his) – Bristol Myers Squibb
### he/him/his @@@ Amita Joshi, PhD (she/her/hers) – Genentech ### 2121876###Speaker###Vice President, Clinical Pharmacology###Genentech###Speaker: Amita Joshi, PhD (she/her/hers) – Genentech
### she/her/hers @@@ Adeniyi Olagunju, PhD (he/him/his) – University of Liverpool ### 2121877###Speaker###Senior Lecturer###University of Liverpool###Speaker: Adeniyi Olagunju, PhD (he/him/his) – University of Liverpool
### he/him/hisChair: Tomoyuki Mizuno, PhD – Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center
Chair: Iris K. Minichmayr, PhD (she/her/hers) – Medical University of Vienna
Speaker: Jean-Baptiste Woillard, PharmD, PhD (he/him/his) – Limoges University Hospital, Inserm U1248, University of Limoges
Speaker: Jasmine Hannah Hughes, PhD (she/her/hers) – InsightRX
Speaker: Ethan Poweleit – Cincinnati Children's Hospital Medical Center
Precision Dosing (PD)
Pharmacometrics & Pharmacokinetics (PMK)
Chair: Tomoyuki Mizuno, PhD – Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center
### @@@ Iris K. Minichmayr, PhD (she/her/hers) – Medical University of Vienna ### 2121881###Chair###Assistant Professor of Clinical Pharmacometrics, Pharmacist###Medical University of Vienna###Chair: Iris K. Minichmayr, PhD (she/her/hers) – Medical University of Vienna
### she/her/hers @@@ Jean-Baptiste Woillard, PharmD, PhD (he/him/his) – Limoges University Hospital, Inserm U1248, University of Limoges ### 2121882###Speaker###Professeur des Universités Praticien Hospitalier (PUPH)###Limoges University Hospital, Inserm U1248, University of Limoges###Speaker: Jean-Baptiste Woillard, PharmD, PhD (he/him/his) – Limoges University Hospital, Inserm U1248, University of Limoges
### he/him/his @@@ Jasmine Hannah Hughes, PhD (she/her/hers) – InsightRX ### 2121883###Speaker###Director of Data Science###InsightRX###Speaker: Jasmine Hannah Hughes, PhD (she/her/hers) – InsightRX
### she/her/hers @@@ Ethan Poweleit – Cincinnati Children's Hospital Medical Center ### 1144043###Speaker###PhD Candidate###Cincinnati Children's Hospital Medical Center###Speaker: Ethan Poweleit – Cincinnati Children's Hospital Medical Center
###Chair: Robert E. Stratford, Jr., PhD (he/him/his) – Otsuka-US
Chair: Gina Pastino, PhD (she/her/hers) – Cerevel Therapeutics
Speaker: John McCorvy, PhD – Medical College of Wisconsin
Speaker: Matthew W. Johnson, PhD – Johns Hopkins University
Mental Health & Addiction (MHA)
Chair: Robert E. Stratford, Jr., PhD (he/him/his) – Otsuka-US
### he/him/his @@@ Gina Pastino, PhD (she/her/hers) – Cerevel Therapeutics ### 1770967###Chair###Senior Director###Cerevel Therapeutics###Chair: Gina Pastino, PhD (she/her/hers) – Cerevel Therapeutics
### she/her/hers @@@ John McCorvy, PhD – Medical College of Wisconsin ### 2121866###Speaker###Assistant Professor###Medical College of Wisconsin###Speaker: John McCorvy, PhD – Medical College of Wisconsin
### @@@ Matthew W. Johnson, PhD – Johns Hopkins University ### 2121867###Speaker###Professor###Johns Hopkins University###Speaker: Matthew W. Johnson, PhD – Johns Hopkins University
###Chair: Virginia (Ginny) D. Schmith, PhD – Schmith PK/PD Consulting LLC
Chair: Akinyemi O. Oni-Orisan, PharmD, PhD (he/him/his) – University of California, San Francisco
Chair: Virginia (Ginny) D. Schmith, PhD – Schmith PK/PD Consulting LLC
### @@@ Akinyemi O. Oni-Orisan, PharmD, PhD (he/him/his) – University of California, San Francisco ### 862400###Chair###Associate Professor###University of California, San Francisco###Chair: Akinyemi O. Oni-Orisan, PharmD, PhD (he/him/his) – University of California, San Francisco
### he/him/hisChair: Navin Goyal, PhD – Johnson and Johnson
Speaker: Rajendra P. Singh, PhD – Teva Pharmaceuticals
Speaker: Yuqing Gong, PhD (she/her/hers) – U.S. Food and Drug Administration
Early Career (EC)
Regulatory Science (RS)
Chair: Navin Goyal, PhD – Johnson and Johnson
### @@@ Rajendra P. Singh, PhD – Teva Pharmaceuticals ### 2147033###Speaker###Senior Director###Teva Pharmaceuticals###Speaker: Rajendra P. Singh, PhD – Teva Pharmaceuticals
### @@@ Yuqing Gong, PhD (she/her/hers) – U.S. Food and Drug Administration ### 1143796###Speaker###Pharmacologist###U.S. Food and Drug Administration###Speaker: Yuqing Gong, PhD (she/her/hers) – U.S. Food and Drug Administration
### she/her/hersChair: Zhu Zhou, PhD (she/her/hers) – City University of New York
Chair: Liang Zhao, PhD, MBA – US Food and Drug Administration
Speaker: Anshul Kanakia, PhD (he/him/his) – AstraZeneca
Speaker: Mark Sale, MD (he/him/his) – Certara
Speaker: Liang Zhao, PhD, MBA – US Food and Drug Administration
Regulatory Science (RS)
Pharmacometrics & Pharmacokinetics (PMK)
Chair: Zhu Zhou, PhD (she/her/hers) – City University of New York
### she/her/hers @@@ Liang Zhao, PhD, MBA – US Food and Drug Administration ### 1143392###Chair###Division Director###US Food and Drug Administration###Chair: Liang Zhao, PhD, MBA – US Food and Drug Administration
### @@@ Anshul Kanakia, PhD (he/him/his) – AstraZeneca ### 2188216###Speaker###Director, Data Science###AstraZeneca###Speaker: Anshul Kanakia, PhD (he/him/his) – AstraZeneca
### he/him/his @@@ Mark Sale, MD (he/him/his) – Certara ### 2121851###Speaker###Vice President###Certara###Speaker: Mark Sale, MD (he/him/his) – Certara
### he/him/his @@@ Liang Zhao, PhD, MBA – US Food and Drug Administration ### 1143392###Speaker###Division Director###US Food and Drug Administration###Speaker: Liang Zhao, PhD, MBA – US Food and Drug Administration
###